Japan Infection Control Supplies Market By Type (Equipment, Services, Consumables), By End User (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationJapan Infection Control Supplies Market By Type (Equipment, Services, Consumables), By End User (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
| Forecast Period | 2026-2030 |
| Market Size (2024) | USD 974.85 Million |
| Market Size (2030) | USD 1478.02 Million |
| CAGR (2025-2030) | 7.14% |
| Fastest Growing Segment | Consumables |
| Largest Market | Kanto |
Market Overview
Japan Infection Control Supplies Market was valued at USD 974.85
Key Market Drivers
Rising Incidence of Healthcare-Associated Infections (HAIs)
The incidence of healthcare-associated infections (HAIs) in Japan is a major driver of the Japan Infection Control Supplies Market. HAIs, including infections acquired during hospital stays or healthcare procedures, represent a significant concern within the healthcare system due to their impact on patient outcomes and healthcare costs. In Japan, the prevalence of HAIs has prompted increased vigilance and investment in infection control practices across healthcare settings. Healthcare-associated infections encompass a range of conditions such as surgical site infections, catheter-associated urinary tract infections, central line-associated bloodstream infections, and ventilator-associated pneumonia. These infections not only complicate patient care but also contribute to prolonged hospital stays, increased healthcare costs, and, in severe cases, patient mortality. To combat these issues, healthcare facilities in Japan are prioritizing the implementation of comprehensive infection control measures.
In response to the growing incidence of HAIs, there has been a notable surge in demand for various infection control supplies. Hospitals and clinics are investing in advanced disinfectants, sterilization equipment, and personal protective equipment (PPE) to enhance their infection control protocols. For example, surface disinfectants and high-level disinfectants are crucial for decontaminating hospital environments, while sterilization products are essential for ensuring that medical instruments are free from pathogenic microorganisms. The increased focus on preventing HAIs is supported by national and regional healthcare guidelines that mandate stringent infection control practices. These guidelines often require healthcare facilities to adopt evidence-based protocols and utilize specific infection control products to minimize the risk of infections. As a result, there is a growing market for infection control supplies that meet these regulatory standards and address the challenges posed by HAIs.
The rise in HAIs has led to greater awareness among healthcare professionals and the public about the importance of infection prevention. This awareness drives demand for infection control products and services, as stakeholders seek solutions to reduce infection rates and improve patient safety. The continuous evolution of infection control strategies and the development of new technologies further contribute to market growth, as healthcare facilities seek innovative solutions to address emerging infection threats.
Technological Advancements
n July 2020, Omron Asia Pacific announced a partnership with Techmetics Robotics LLC to introduce the OMRON LD-UVC mobile robot. This new disinfection robot incorporates advanced features designed to enhance pathogen elimination, safety, and autonomy. Omron highlighted that UVC light effectively disrupts pathogens' DNA and RNA, rendering them unable to replicate. The OMRON LD-UVC robot is capable of autonomous navigation and can disinfect various areas, including high-touch surfaces, by delivering precise doses of UVC energy. The company claims that the robot can eliminate up to 99.90% of both airborne and droplet bacteria and viruses.
The design and materials used in personal protective equipment (PPE) have also seen significant improvements. New materials with enhanced barrier properties and comfort features contribute to better protection and usability for healthcare workers. Innovations in PPE include the development of multi-layered masks with higher filtration efficiency, as well as ergonomic designs that improve fit and comfort during extended use. Advancements in infection control technology extend beyond traditional products to include smart and connected solutions. For example, IoT-enabled disinfection systems allow for real-time monitoring and management of infection control measures. These smart technologies provide valuable data and insights to optimize infection prevention strategies and ensure compliance with hygiene protocols. The continuous evolution of infection control technologies drives market growth by addressing emerging infection threats and meeting the demands of modern healthcare environments. As new technologies are developed and launched, healthcare facilities seek to adopt the latest solutions to improve infection control practices and enhance patient safety. The ongoing investment in research and development by manufacturers and suppliers contributes to the expansion of the Japan Infection Control Supplies Market and the availability of innovative products.
Aging Population and Chronic Disease Management
Japan's aging population and the rising prevalence of chronic diseases are significant drivers of the Japan Infection Control Supplies Market. As Japan experiences one of the world’s most rapidly aging populations, there is an increasing demand for medical care and long-term health management, which in turn drives the need for effective infection control measures. Elderly individuals are more susceptible to infections due to age-related declines in immune function, multiple comorbidities, and increased frequency of medical treatments. This vulnerability necessitates stringent infection control practices in both healthcare settings and long-term care facilities. For instance, elderly patients often require hospitalization or residential care, where the risk of infections such as healthcare-associated infections (HAIs) and opportunistic infections is higher. Consequently, healthcare providers are compelled to implement robust infection control protocols to safeguard these patients. Chronic diseases, including diabetes, cardiovascular conditions, and respiratory disorders, further exacerbate infection risks. Individuals with chronic conditions are more prone to infections and often need ongoing medical care, which increases their exposure to healthcare settings where infection control is crucial. Managing chronic diseases requires consistent use of infection control products such as antiseptics, wound care supplies, and specialized cleaning agents to prevent complications and ensure effective treatment.
The growing need for infection control measures in long-term care facilities, including nursing homes and assisted living centers, reflects the broader trend of addressing the health needs of the elderly population. As these facilities expand and upgrade their services to accommodate more residents, they invest in infection control supplies to maintain hygiene standards and prevent outbreaks of infections. The Japanese government and healthcare organizations are actively focusing on improving the quality of care for the elderly, which includes enhancing infection control practices. This focus translates into increased demand for infection control products and services designed to meet the specific needs of the aging population. The continued growth of Japan’s elderly population and the management of chronic diseases are key factors driving sustained market growth for infection control supplies.
Growth in the Health and Wellness Sector
The growth of the health and wellness sector is an emerging driver of the Japan Infection Control Supplies Market. As awareness of health and wellness continues to rise, there is a corresponding increase in demand for products and practices that contribute to overall well-being, including infection control measures. In recent years, there has been a significant shift towards preventative health and proactive management of personal and environmental hygiene. This trend is reflected in the growing popularity of health and wellness products, including those focused on infection prevention. Consumers are increasingly seeking products that offer enhanced protection against infections and support a healthy lifestyle, driving demand for items such as high-quality hand sanitizers, antimicrobial cleaning products, and air purifiers.
The health and wellness sector encompasses a wide range of products and services aimed at improving quality of life and maintaining health. This includes not only personal hygiene products but also environmental sanitation solutions designed to reduce the risk of infections in various settings. For example, fitness centers, spas, and wellness retreats are investing in advanced infection control measures to ensure a clean and safe environment for their clients. The integration of infection control practices into health and wellness routines reflects a growing understanding of the role that hygiene plays in overall health. As more individuals and organizations adopt infection control measures as part of their health and wellness strategies, the market for infection control supplies expands, driven by the demand for products that support a healthy and hygienic lifestyle.
Key Market Challenges
High Costs of Advanced Infection Control Products
The high costs associated with advanced infection control products present a significant challenge in the Japan Infection Control Supplies Market. Innovative infection control solutions, such as advanced disinfectants, high-efficiency sterilization equipment, and sophisticated personal protective equipment (PPE), often come with substantial price tags. These costs can pose barriers to widespread adoption, particularly for smaller healthcare facilities and organizations with limited budgets. Advanced infection control products are typically developed with cutting-edge technologies and materials, which contribute to their higher costs. For instance, high-efficiency sterilizers and automated disinfection systems involve complex engineering and specialized components, driving up their price. Similarly, PPE designed with advanced materials and enhanced protective features can be significantly more expensive than standard alternatives.
The high costs of these products can impact healthcare facilities' ability to invest in and maintain comprehensive infection control measures. Budget constraints may force facilities to prioritize essential items over advanced solutions, potentially compromising the effectiveness of their infection control practices. This is particularly challenging for public health institutions and smaller clinics that operate under tight financial constraints.
The cost of infection control supplies can also affect the pricing and availability of products in the market. Higher costs may lead to increased prices for end-users, potentially limiting access to essential infection control measures for healthcare providers and consumers. This can create disparities in the quality of infection control practices across different regions and types of facilities. Addressing the challenge of high costs requires a multi-faceted approach, including efforts to reduce manufacturing costs, explore cost-effective alternatives, and advocate for policies that support affordability and accessibility. Collaboration between manufacturers, healthcare providers, and policymakers can help ensure that advanced infection control solutions are found at and accessible to those who need them.
Supply Chain Disruptions
Supply chain disruptions are a significant challenge for the Japan Infection Control Supplies Market, impacting the availability and timely delivery of essential products. The COVID-19 pandemic has highlighted vulnerabilities in global supply chains, affecting the production and distribution of infection control supplies. These disruptions have resulted in shortages, delays, and increased costs for products crucial to infection prevention and control. Several factors contribute to supply chain disruptions in the Japan Infection Control Supplies Market. For one, the global demand for infection control products surged during the pandemic, leading to supply shortages and increased competition for raw materials. Manufacturers faced challenges in sourcing essential components and materials, impacting their ability to produce and deliver products on time.
Logistical challenges, including transportation delays and border restrictions, also played a role in supply chain disruptions. International shipping and distribution networks were strained by increased demand and pandemic-related restrictions, leading to delays in the delivery of products to Japan. This was particularly problematic for time-sensitive products such as PPE and disinfectants, which are critical for managing infection outbreaks.
Disruptions in the supply chain can result in increased costs for manufacturers and consumers. Rising prices for raw materials and shipping can lead to higher product costs, which may be passed on to end-users. This can create financial pressures for healthcare facilities and organizations, especially those operating under budget constraints. To mitigate the impact of supply chain disruptions, companies in the Japan Infection Control Supplies Market must adopt strategies to enhance supply chain resilience. This includes diversifying supply sources, investing in inventory management, and establishing contingency plans for unforeseen disruptions. Collaboration with suppliers, logistics partners, and government authorities can also help address supply chain challenges and ensure the availability of essential infection control products.
Key Market Trends
Increased Focus on Infection Control in Non-Healthcare Settings
Beyond traditional healthcare environments, there is a growing recognition of the need for effective infection control measures in various public and private settings, including educational institutions, offices, public transportation, and commercial establishments. The COVID-19 pandemic has heightened awareness of infection control practices in non-healthcare environments, leading to a surge in demand for products such as disinfectants, air purifiers, and hygiene solutions. Schools and educational institutions, for example, have implemented enhanced cleaning protocols and invested in infection control supplies to ensure the safety of students and staff. Similarly, businesses and offices have adopted stricter hygiene measures, including regular disinfection of high-touch surfaces and the provision of hand sanitizers, to protect employees and customers.
Public transportation systems, including trains and buses, have also seen increased investment in infection control measures. To maintain passenger safety and prevent the spread of infections, transportation authorities have launched routine cleaning and disinfection procedures, as well as upgraded air filtration systems. Commercial establishments, including restaurants, hotels, and retail retailers, have similarly adopted infection control practices to reassure customers and ensure a safe environment. The emphasis on infection control in these diverse settings reflects a broader shift towards maintaining hygiene and preventing the spread of infections in everyday life. This trend drives the demand for infection control products that are suitable for a variety of environments, including those that require frequent and effective sanitation solutions. As organizations across different sectors continue to prioritize infection control, the market for these supplies is expected to grow, with opportunities for innovation and expansion in both product offerings and applications.
Rising Investment in Research and Development
In January 2021 H. IKEUCHI & CO., LTD., a prominent Japanese manufacturer of industrial and commercial spray nozzles, officially launched the full-scale sales of its new backpack disinfection device, named "Dry-Fog HIGHNOW." The Dry-Fog HIGHNOW (DFH) is a backpack-style disinfection device that utilizes a patented nozzle from IKEUCHI to dispense a disinfectant solution as "Dry Fog," with droplets measuring 10 micrometers or less.
Segmental Insights
Type Insights
Based on the type, Consumables currently dominate as the leading segment in the Japan Infection Control Supplies Market, a position underscored by their fundamental role in maintaining effective infection control across a variety of settings, from healthcare facilities to public spaces. This prominence arises from the indispensable nature of consumable items, which are integral to preventing the spread of infections and ensuring rigorous hygiene standards. The consumables segment includes a diverse array of products, each contributing uniquely to infection control and public health. Personal protective equipment (PPE) represents a cornerstone of the consumables market. PPE includes essential items such as gloves, masks, gowns, and face shields. The COVID-19 pandemic has dramatically highlighted the critical importance of PPE. Healthcare workers, who are at the forefront of managing infectious diseases, rely heavily on these protective items to shield themselves and their patients from pathogens. The heightened global focus on infection prevention during the pandemic led to a surge in the production and consumption of PPE, a trend that continues as organizations and individuals maintain heightened awareness of hygiene. The demand for PPE is sustained not only by healthcare facilities but also by a range of public and private sectors, including education, retail, and transportation, where protection against infectious agents is crucial.
Disinfectants and antiseptics form another vital component of the consumables segment. These products are essential for the effective cleaning and sanitizing of surfaces and hands, playing a crucial role in preventing cross-contamination and reducing the risk of infection. Disinfectants are widely used in healthcare environments, such as hospitals and clinics, where maintaining sterile conditions is imperative. Their use extends to public spaces and commercial settings where regular cleaning is necessary to ensure a hygienic environment. The rise in awareness about the role of hygiene in preventing disease transmission has led to sustained demand for effective disinfectants and antiseptics, which are found at in various formulations to meet different needs.
End User Insights
Based on end user, hospitals are the dominant segment. This dominance is primarily due to the critical and continuous need for infection control measures within healthcare settings, where the risks of infection are highest and the stakes are most significant. Hospitals require a comprehensive array of infection control supplies to ensure the safety of patients, staff, and visitors, driving a substantial and consistent demand for these products. Hospitals, as major healthcare providers, are at the forefront of implementing stringent infection control protocols. They are essential environments where the risk of healthcare-associated infections (HAIs) is considerable due to the presence of immunocompromised patients and invasive procedures. This necessitates the regular use of a wide variety of infection control supplies, including personal protective equipment (PPE), disinfectants, antiseptics, hand sanitizers, and cleaning agents.
Personal protective equipment (PPE) is particularly critical in hospital settings. Items such as gloves, masks, gowns, and face shields are essential for protecting healthcare workers from exposure to infectious agents. The importance of PPE in preventing the spread of infections within hospitals cannot be overstated, and the high demand for these products within hospital settings drives a significant portion of the Japan Infection Control Supplies Market. The COVID-19 pandemic has further emphasized the necessity of PPE, leading to increased procurement and usage across hospitals. Disinfectants and antiseptics also play a crucial role in hospitals. Hospitals require potent disinfectants for cleaning and sanitizing surfaces, medical equipment, and hands to prevent cross-contamination and the spread of infections. The rigorous cleaning protocols in hospitals ensure that all surfaces and equipment are free of pathogens, which is critical for maintaining a sterile environment. This necessity drives continual procurement of disinfectants and antiseptics, contributing to their dominance in the infection control Japan Infection Control Supplies Market.
Regional Insights
Kanto stands out as the dominant region in the Japan Infection Control Supplies Market. The Kanto region, which includes the capital city of Tokyo and other major urban centers such as Yokohama, Chiba, and Saitama, exerts a significant influence on the market due to its large population, high density of healthcare facilities, and substantial economic activity. The dominance of Kanto in the Japan Infection Control Supplies Market is primarily driven by the concentration of healthcare institutions in this region. Tokyo, as Japan's capital, is home to numerous major hospitals, medical research institutions, and healthcare facilities that require a vast array of infection control supplies. The high number of medical facilities in Tokyo and its surrounding prefectures generates substantial demand for products such as personal protective equipment (PPE), disinfectants, antiseptics, hand sanitizers, and cleaning agents. The need for robust infection control measures is amplified in this densely populated region, where the risk of disease transmission is heightened due to the high volume of people and frequent interactions.
Recent Developments
- In March 2024, AWTechnologies and Asahi Kasei Medical, a key entity of the Asahi Kasei Group,have established an exclusive distribution agreement for the TrachFlushâ„¢ devicein Japan. AW Technologies is in the process of registering the TrachFlush as amedical device in Japan, with plans to launch the product in fiscal year 2024. TheTrachFlush, developed by AW Technologies and based on an innovation by anintensivist, is designed to alleviate discomfort for ventilated patients andease the burden on healthcare professionals during tracheal suctioning. Thisdevice aids in managing airway secretions (phlegm) through a distinctive cuffpressure control system. It has already received the CE Mark in Europe in 2020and FDA clearance in the United States in 2023. In Japan, the marketing andsales of the TrachFlush will be handled by Asahi Kasei Medical.
- In June 2023, Japaneseelectronics leader Panasonic introduced its innovative smart wardrobe, theHCC-R600A, featuring a range of advanced functionalities. This cutting-edgewardrobe can silently disinfect, deodorize, and iron clothes while operatingquietly, ensuring it does not disturb anyone who is sleeping. The smartwardrobe comes in two sub-models, designated left (L) and right (R), based onthe direction in which the door opens. Tested by the Japanese Food ResearchCenter, the Panasonic smart wardrobe is capable of reducing bacteria onclothing by up to 99%, achieving this level of disinfection after just twohours of operation.
- In June 2023, Japaneseanalytical instrumentation firm Shimadzu Corporation partnered with US-based AIand robotics specialist Shyld to advance a cutting-edge AI-powered ultravioletC (UV-C) disinfection technology. This innovative technology integratesShimadzu’s expertise in optics with Shyld’s advancements in AI, aiming totransform the infection control sector. At Stanford Medical Center inCalifornia, the Shyld AI disinfection technology has been installed in patientrooms to automatically detect potential risks in real time and deploy UV-Clight to eradicate pathogens from various surfaces.
Key Market Players
- 3M Japan Limited
- Getinge Group Japan Co., Ltd.
- ASP Japan LLC
- Steris Japan Co., Ltd.
- Taiko Pharmaceutical Co., Ltd.
- Airtech Japan, Ltd.
- Japan Vilene Company, Ltd.
| By Type | By End User | By Region |
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy